Toropainen, E.; Fraser-Miller, S.J.; Novakovic, D.; Del Amo, E.M.; Vellonen, K.-S.; Ruponen, M.; Viitala, T.; Korhonen, O.; Auriola, S.; Hellinen, L.;
et al. Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin. Pharmaceutics 2021, 13, 452.
https://doi.org/10.3390/pharmaceutics13040452
AMA Style
Toropainen E, Fraser-Miller SJ, Novakovic D, Del Amo EM, Vellonen K-S, Ruponen M, Viitala T, Korhonen O, Auriola S, Hellinen L,
et al. Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin. Pharmaceutics. 2021; 13(4):452.
https://doi.org/10.3390/pharmaceutics13040452
Chicago/Turabian Style
Toropainen, Elisa, Sara J. Fraser-Miller, Dunja Novakovic, Eva M. Del Amo, Kati-Sisko Vellonen, Marika Ruponen, Tapani Viitala, Ossi Korhonen, Seppo Auriola, Laura Hellinen,
and et al. 2021. "Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin" Pharmaceutics 13, no. 4: 452.
https://doi.org/10.3390/pharmaceutics13040452
APA Style
Toropainen, E., Fraser-Miller, S. J., Novakovic, D., Del Amo, E. M., Vellonen, K.-S., Ruponen, M., Viitala, T., Korhonen, O., Auriola, S., Hellinen, L., Reinisalo, M., Tengvall, U., Choi, S., Absar, M., Strachan, C., & Urtti, A.
(2021). Biopharmaceutics of Topical Ophthalmic Suspensions: Importance of Viscosity and Particle Size in Ocular Absorption of Indomethacin. Pharmaceutics, 13(4), 452.
https://doi.org/10.3390/pharmaceutics13040452